HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katerina Zavitsanou Selected Research

AFDX 384

1/2007Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
5/2005M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katerina Zavitsanou Research Topics

Disease

21Schizophrenia (Dementia Praecox)
07/2017 - 11/2002
3Psychotic Disorders (Schizoaffective Disorder)
06/2013 - 01/2011
3Body Weight (Weight, Body)
11/2010 - 04/2005
2Inflammation (Inflammations)
01/2017 - 06/2013
2Cognitive Dysfunction
01/2013 - 09/2010
2Obesity
12/2006 - 04/2005
2Mental Disorders (Mental Disorder)
09/2006 - 03/2004
2Bipolar Disorder (Manic Depressive Psychosis)
05/2005 - 03/2004
1Virus Diseases (Viral Diseases)
08/2016
1Encephalitis (Encephalitis, Rasmussen)
06/2013
1Infections
01/2012
1Paranoid Schizophrenia (Delusional Disorder)
07/2011
1Substance-Related Disorders (Drug Abuse)
01/2011
1Weight Gain
08/2006
1Mood Disorders (Mood Disorder)
05/2005

Drug/Important Bio-Agent (IBA)

9CannabinoidsIBA
08/2016 - 03/2004
5Messenger RNA (mRNA)IBA
01/2013 - 04/2005
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017 - 11/2002
3Poly I-CIBA
07/2017 - 07/2014
3CB1 Cannabinoid Receptor (CB1 Receptor)IBA
07/2011 - 07/2009
3PirenzepineIBA
01/2007 - 03/2004
2Serotonin (5 Hydroxytryptamine)IBA
06/2013 - 01/2012
2Dopamine (Intropin)FDA LinkGeneric
06/2013 - 04/2005
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2013 - 03/2004
2gamma-Aminobutyric Acid (GABA)IBA
01/2013 - 01/2007
2MuscimolIBA
01/2013 - 01/2007
2Phencyclidine (Angel Dust)IBA
08/2011 - 10/2008
2HU 211 (HU 210)IBA
11/2010 - 07/2009
2Pharmaceutical PreparationsIBA
10/2008 - 02/2008
2N-Methylaspartate (NMDA)IBA
10/2008 - 11/2002
2AMPA Receptors (AMPA Receptor)IBA
10/2008 - 11/2002
2Cholinergic Agents (Cholinergics)IBA
01/2007 - 03/2004
2AFDX 384IBA
01/2007 - 05/2005
2Dizocilpine Maleate (Dizocilpine)IBA
08/2005 - 11/2002
2Ionotropic Glutamate ReceptorsIBA
08/2005 - 11/2002
2Kainic Acid (Kainate)IBA
08/2005 - 11/2002
2Muscarinic M4 ReceptorIBA
05/2005 - 03/2004
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
07/2017
1Glutamic Acid (Glutamate)FDA Link
01/2017
1MicroRNAs (MicroRNA)IBA
08/2016
1Epidermal Growth Factor (EGF)IBA
01/2016
1EndocannabinoidsIBA
07/2014
1Flumazenil (Romazicon)FDA LinkGeneric
01/2013
1BenzodiazepinesIBA
01/2013
1Excitatory Amino Acid AntagonistsIBA
10/2008
1Proteins (Proteins, Gene)FDA Link
02/2008
1Muscarinic M1 ReceptorIBA
02/2008
1GABA Receptors (GABA Receptor)IBA
01/2007
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2007
1GABA-A Receptors (GABA(A) Receptor)IBA
01/2007
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2006
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
09/2006
1Protein Isoforms (Isoforms)IBA
09/2006
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
08/2006
1Antipsychotic Agents (Antipsychotics)IBA
06/2006
1PropionatesIBA
08/2005
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
04/2005
1RimonabantIBA
03/2004
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
03/2004
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
11/2002
1IsoxazolesIBA
11/2002
1Kainic Acid Receptors (Kainate Receptor)IBA
11/2002
1propionic acid (potassium propionate)IBA
11/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
02/2008 - 05/2005